Medical Condition News

RSS

neuGRID now expands globally to help find treatments for AD

neuGRID, a cloud-computing infrastructure funded by the European Commission that stores and analyses a vast database of 3D brain scans, is now expanding globally to help find treatments for Alzheimer's. This ground-breaking initiative will help develop a global online system to centralise and boost Alzheimer's research initiatives.

20 Feb 2012

ASI receives FDA clearance for GenASIs Scan and Analysis

Applied Spectral Imaging (ASI) announces that ASI's GenASIs automated scanning and image analysis system for detection and quantifying chromosome 17 and the HER-2/neu gene has been cleared by the United States Food and Drug Administration (FDA) for marketing in the US.

20 Feb 2012

Autism may be evident in an infant’s brain much earlier than thought: Study

Researchers have found that autism shows tell tale signs in babies as young as 6 months old — half a year or more before parents typically begin to notice symptoms of the condition. The results shed light on the fundamental differences in the brains of autistic children and could help lead to earlier detection and treatment, says co-author Geraldine Dawson, chief science officer at Autism Speaks, which helped fund the study in today's American Journal of Psychiatry.

20 Feb 2012

Apixio introduces Clinical Knowledge Exchange at HIMSS 2012 conference

Apixio, Inc., the leading provider of clinical data integration, search and analytics for healthcare organizations, is introducing this week at the HIMSS 2012 conference, a technology framework called the Clinical Knowledge Exchange.

20 Feb 2012

Natural compound of Chilean avocado plant can combat resistant yellow staphylococci

Aggressive infections in hospitals are an increasing health problem worldwide. The development of bacterial resistance is alarming. Now a young Danish scientist has found a natural substance in a Chilean rainforest plant that effectively supports the effect of traditional treatment with antibiotics.

20 Feb 2012

Gender identity disorder linked with mental health risk in children

The first study to characterize a cohort of U.S. children with diagnosed gender identity disorder, led by researchers at Children's Hospital Boston, documents significant mental health risks as children struggle with strong feelings of being born "in the wrong body."

20 Feb 2012

New intraoral Tongue Drive System for high-level SCIs

The Tongue Drive System is getting less conspicuous and more capable. Tongue Drive is a wireless device that enables people with high-level spinal cord injuries to operate a computer and maneuver an electrically powered wheelchair simply by moving their tongues.

20 Feb 2012

EC approves Plexxikon's Zelboraf to treat BRAF mutation-positive MM

Plexxikon Inc., a member of Daiichi Sankyo Group, today announced that the European Commission has approved Zelboraf (vemurafenib) for the monotherapy treatment of adult patients with BRAFV600 mutation-positive unresectable or metastatic melanoma.

20 Feb 2012

Indiana CTSI HUB offers open-source software to accelerate clinical and translational research

At a time when medical research increasingly requires collaboration by large numbers of busy people, the Indiana Clinical and Translational Science Institute HUB offers a model for using advanced information technology to link scientists, health providers, community partners and others for the purpose of accelerating clinical and translational research.

20 Feb 2012

Substituting smokeless tobacco products can save smokers' lives

Substituting smokeless tobacco products can save smokers' lives, and there is a scientific foundation that proves it.

20 Feb 2012

Study identifies USP15 as a critical protein in cancer

After years studying the molecular bases of glioblastoma - the most common brain tumor and one of the most aggressive of all cancers, the group led by Dr. Joan Seoane , Director of Translational Research at the Vall d'Hebron Institute of Oncology (VHIO) and ICREA Research Professor has today published a study in Nature Medicine identifying USP15 as a critical protein in cancer which, thanks to its molecular characteristics, shows enormous therapeutic promise.

20 Feb 2012

Modified imatinib cancer drug prevents morphine tolerance in rats

By reformulating the common cancer drug imatinib (Gleevec), researchers have eliminated morphine tolerance in rats - an important step toward improving the effectiveness of chronic pain management in patients, according to researchers at The University of Texas MD Anderson Cancer Center.

20 Feb 2012

Smoke forecasting tools can help protect individuals and public health professionals

Satellite images, air quality measurements and smoke forecasting models are useful tools to help individuals and public health professionals prepare for smoke episodes in areas at risk from forest fire smoke, according to University of British Columbia researcher Michael Brauer.

20 Feb 2012

Defects in GPR120 protein may lead to obesity and liver disease

Defects in a protein that functions as a dietary fat sensor may be a cause of obesity and liver disease, according to a study published in the journal Nature, led by researchers at Imperial College London. The findings highlight a promising target for new drugs to treat obesity and metabolic disorders.

19 Feb 2012

Penn oncologist to discuss role of autophagy in fighting cancer at AAAS annual meeting

Blocking autophagy -- the process of "self-eating" within cells -- is turning out to be a viable way to enhance the effectiveness of a wide variety of cancer treatments.

19 Feb 2012

Clazosentan drug shows promise against TBI in rats

A new drug is showing promise in shielding against the harmful effects of traumatic brain injury (TBI) in rats, according to a study that was released today and will be presented at the American Academy of Neurology's 64th Annual Meeting in New Orleans April 21 to April 28, 2012.

19 Feb 2012

Protein fragments from yellow field pea seeds can lower blood pressure

There are lots of new ideas out there for giving you extra protection against chronic diseases through the food you eat. But many good ideas may never make it to market. Researchers at the University of Guelph, led by Brian McBride, have found a way to enrich milk with docosahexaeonic acid (DHA)-an essential nutrient that many people are lacking.

19 Feb 2012

Evolution of cancer genome to be discussed at 2012 AAAS annual meeting

Professor Mike Stratton, Director of the Wellcome Trust Sanger Institute, will speak about 'the evolution of the cancer genome' at the prestigious 2012 American Association for the Advancement of Science annual meeting. The AAAS annual meeting is one of the world's most widely recognized science events.

19 Feb 2012

Botox efficacy uncertain in treating migraine says NICE

Botox – used as an anti-wrinkle agent - is unlikely to be recommended for the treatment of chronic migraines on the NHS in England and Wales. According to the National Institute for Health and Clinical Excellence (NICE) draft guidelines there is insufficient evidence that it works.

18 Feb 2012

Remote controlled microchip successfully delivers drug in early clinical trial

Researchers have developed a new microchip implant device that can deliver bone-building drugs to seven osteoporosis patients. The microchips worked inside patients as drug-delivering pacemakers, following a prescription plan sent by radio signal.

18 Feb 2012